NDC 70518-4495-00 - Metronidazole
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4495
- Requested NDC
- 70518-4495-00
- Package NDCs from labels
- 70518-4495-0, 70518-4495-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Metronidazole - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4495-0 | Metronidazole | 70 g in 1 TUBE, WITH APPLICATOR | GEL | 70 | 1 | |
| 70518-4495-0 | Metronidazole | 1 in 1 CARTON | GEL | 1 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| metronidazole | METRONIDAZOLE | Method Pharmaceuticals LLC | 2ae49bf4-a23b-bdcc-e063-6294a90a80a9 | 2026-05-04 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| metronidazole | METRONIDAZOLE | ST. MARY'S MEDICAL PARK PHARMACY | e3a32908-9db1-6ca7-e053-2a95a90a82fb | 2026-05-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Coupler LLC | 509c8d03-e199-8154-e063-6394a90afddc | 2026-04-29 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Northstar Rx LLC | 65cda174-d840-488a-96d0-74d6086b7048 | 2026-04-17 | Warnings, Adverse reactions | 142046 140QMO216E |
| Metronidazole | METRONIDAZOLE | St. Mary's Medical Park Pharmacy | 60689b96-cb58-925a-e053-2a91aa0a32a3 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | H2-Pharma, LLC | c29bfde9-5eb4-422a-bd30-4bce45e73dc0 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Bryant Ranch Prepack | 1277591d-ccf4-428a-b647-cb1ef3fbf561 | 2026-04-13 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride | BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE | Par Health USA, LLC | c4d66e80-f0bc-4e64-a0f0-630ef673da1b | 2026-04-03 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 02046a22-a5eb-4bb7-bec7-e5a2aa55e142 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | NuCare Pharmaceuticals,Inc. | c225a455-ec25-2213-e053-2995a90a3389 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | REMEDYREPACK INC. | ca450fad-0513-4c45-8ea0-1f46bcbf6a36 | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | BluePoint Laboratories | 3cf021b6-5794-4a86-b09d-bece0ba8b302 | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Viona Pharmaceuticals Inc | 40a8c59b-a46d-4e5b-bd38-330cdbc1022c | 2026-02-19 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Zydus Lifesciences Limited | aa7fc40e-64a1-4155-bb39-77ed7b7f2e67 | 2026-02-19 | 140QMO216E | |
| metronidazole vaginal | METRONIDAZOLE | REMEDYREPACK INC. | b8fbd105-90ae-4af4-9313-61834aaf4a2c | 2026-02-13 | Warnings, Adverse reactions | 142046 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | REMEDYREPACK INC. | b07f42dd-75d4-499a-984f-c06894ff3a45 | 2026-02-12 | Warnings, Adverse reactions | 142046 140QMO216E |
| metronidazole | METRONIDAZOLE | Sportpharm LLC | dc8e448e-ac4e-4efc-8851-c368e31b9d69 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Fougera Pharmaceuticals, LLC | 43ed872b-63ac-4a22-9c9e-cc0e05bcc41e | 2026-01-28 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Fougera Pharmaceuticals, LLC | 5368755a-dd37-4e34-843f-ece6bac8ef6a | 2026-01-28 | Adverse reactions | 140QMO216E |
| Firming antibacterial | FIRMING ANTIBACTERIAL | Jiangxi He-Oumei Health Industry Co., Ltd. | 4923cdbf-a3a3-02f4-e063-6394a90ab889 | 2026-01-24 | Warnings | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.